Insider filing · AGL

Benjamin Shaker bought $1.2M of agilon health (AGL)

Executed Mar 14 2025, disclosed Mar 18 2025, 4 days later.

Over the 21 trading sessions from the disclosed entry session (Mar 18 2025), the stock returned +32.9% (delay-adjusted); from the execution session (Mar 14 2025), +39.9%. Derived: entry at the session's open, exit at the close 20 sessions later.

BS Benjamin Shaker Chief Markets Officer profile →

Benjamin Shaker (Chief Markets Officer) filed 2 Form 4 reports in the trailing twelve months (2 purchases, 0 sales), most often in AGL. Across 2 priced purchase filings, the average 21-session return was -15.1% from execution and -4.4% from disclosure (delay-adjusted; derived). The largest single filing was $277K of AGL (as filed, as filed), executed Mar 9.

AGL AGL AGL · 7 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→